Accurate interpretation of the QT interval: A vital task that remains unaccomplished

Heart Rhythm

Volumn 2, Issue 6, 2005, Pages 575-577

  Bai, Rong ^a   Yan, Gan Xin ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Main Line Health Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; PROTEINASE INHIBITOR;

AWARENESS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EDITORIAL; ELECTROCARDIOGRAPHY; HUMAN; LONG QT SYNDROME; MEDICAL EDUCATION; MEDICAL EXPERT; MEDICAL RESEARCH; MEDICAL SPECIALIST; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; SEIZURE; SUDDEN DEATH; SYNCOPE; TORSADE DES POINTES;

CARDIOLOGY; CLINICAL COMPETENCE; DIAGNOSTIC ERRORS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; PHYSICIAN'S PRACTICE PATTERNS;

EID: 19444379686     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.03.005     Document Type: Editorial

References (16)

1. G.M. Vincent K. Timothy L. Zhang Congenital long QT syndrome Card Electrophysiol Rev 6 2002 57-60
2. S. Viskin U. Rosovski A.J. Sands E. Chen P.M. Kistler J.M. Kalman L.R. Chavez F.E.S. Cruz O.S. Centurion A. Fujiki P. Maury X. Chen A. Krahn F. Roithinger L. Zhang M. Vincent D. Zeltser Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one Heart Rhythm 2 2005 569-574
3. S.V. Pacia O. Devinsky D.J. Luciano B. Vazquez The prolonged QT syndrome presenting as epilepsy a report of two cases and literature review Neurology 44 1994 1408-1410
4. M.R. Bell R.J. Kozak Seizures and the long-QT syndrome Ann Emerg Med 28 1996 556-560
5. P. Salen V. Nadkarni Congenital long-QT syndrome: A case report illustrating diagnostic pitfalls J Emerg Med 17 1999 859-864
6. R.C. Owens Jr QT prolongation with antimicrobial agents understanding the significance Drugs 64 2004 1091-1124
7. D.N. Shaffer S.J. Singer Anti-infective Drugs Advisory Committee US Food and Drug Administration Macrolide antibiotics and torsade de pointes postmarketing analysis 2001 Available at: http://www.fda.gov/ohrms/ dockets/ac/01/slides/3746s_02_shaffer_rev.ppt
8. D. Shaffer S. Singer J. Korvick P. Honig Concomitant risk factors in reports of torsades de pointes associated with macrolide use: Review of the United States Food and Drug Administration Adverse Event Reporting System Clin Infect Dis 35 2002 197-200
9. F. De Ponti E. Poluzzi A. Cavalli M. Recanatini N. Montanaro Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview Drug Saf 25 2002 263-286
10. H. Montgomery S. Hunter S. Morris R. Naunton-Morgan R.M. Marshall Interpretation of electrocardiograms by doctors BMJ 309 1994 1551-1552
11. N.M. LaPointe S.M. Al Khatib J.M. Kramer R.M. Califf Knowledge deficits related to the QT interval could affect patient safety Ann Noninvas Electrocardiol 8 2003 157-160
12. A.J. Moss Long QT syndrome JAMA 289 2003 2041-2044
13. G.X. Yan R.S. Lankipalli J.F. Burke S. Musco P.R. Kowey Ventricular repolarization components on the electrocardiogram cellular basis and clinical significance J Am Coll Cardiol 42 2003 401-409
14. N.G. Boyle J.N. Weiss Making QT correction simple is complicated J Cardiovasc Electrophysiol 12 2001 421-423
15. P. Davey How to correct the QT interval for the effects of heart rate in clinical studies J Pharmacol Toxicol Methods 48 2002 3-9
16. P.J. Schwartz A.J. Moss G.M. Vincent R.S. Crampton Diagnostic criteria for the long QT syndrome: An update Circulation 88 1993 782-784